This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Will UnitedHealth's (UNH) Benefits Business Aid Q3 Earnings?
by Zacks Equity Research
Strength in UnitedHealth's (UNH) health service segment is likely to reflect in Q3 results.
What's in the Cards for UnitedHealth (UNH) Earnings in Q3?
by Zacks Equity Research
UnitedHealth's (UNH) Q3 earnings are expected to be benefited from higher revenues and membership growth.
Will Q3 Earnings Drive Dow ETF Higher?
by Sweta Killa
With most blue-chip companies earnings scheduled over the coming weeks and sentiments being mixed, investors should closely monitor the movement of the Dow ETF and grab an opportunity that arises from a surge in any of the 30 stocks.
UnitedHealth Group (UNH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth Expands Medicare Offerings in New Counties
by Zacks Equity Research
UnitedHealth (UNH) is offering Medicare Advantage plans in new counties to reach a greater population of retirees.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $221.24, marking a +0.66% move from the previous day.
Health Insurers Hope to Gain From Executive Order on Medicare
by Sapna Bagaria
President Trump's executive order with focus on Medicare Advantage will probably increase the participation of health insurers in the social benefit program.
Cigna Offers 2020 Medicare Plans with Supplemental Benefits
by Sapna Bagaria
Cigna (CI) is expanding its Medicare Advantage plans across states and counties along with supplemental benefits
UnitedHealth Group (UNH) Stock Moves -0.05%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $217.21, moving -0.05% from the previous trading session.
The Zacks Analyst Blog Highlights: UnitedHealth, Cigna, Anthem and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Cigna, Anthem and Humana
WellCare's Unit to Divest Medicaid Health Plans to Anthem
by Zacks Equity Research
WellCare's (WCG) subsidiary to sell specific Medicaid health plans to Anthem prior to its merger with Centene.
3 Health Insurance Stocks Poised to Beat on Earnings in Q3
by Sapna Bagaria
Growth in government and pharmacy benefit management businesses as well as share buybacks should enhance the third-quarter earnings of health insurers.
The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, GlaxoSmithKline, Duke and BlackRock
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, GlaxoSmithKline, Duke and BlackRock
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $225 in the latest trading session, marking a -1.65% move from the prior day.
UnitedHealth to Offer New Medicare Advantage Plan in Bay Area (Revised)
by Zacks Equity Research
UnitedHealth's (UNH) new Medicare Advantage Plan to serve Medicare beneficiaries in Bay Area.
Top Stock Reports for Facebook, UnitedHealth & GlaxoSmithKline
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), UnitedHealth Group (UNH) and GlaxoSmithKline (GSK).
UnitedHealth to Offer Medicare Advantage Plan in Bay Area
by Zacks Equity Research
UnitedHealth's (UNH) new Medicare Advantage Plan to serve Medicare beneficiaries in Bay Area.
Stock Market News For Sep 20, 2019
by Zacks Equity Research
Benchmarks mostly closed in the green on Thursday on upbeat U.S. housing market as well as gains in Microsoft.
Here's How Cigna (CI) is Poised Amid Political Uncertainty
by Zacks Equity Research
Growth in health services, government business and international markets drive Cigna's (CI) stock.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $234.43, moving +0.35% from the previous trading session.
Zacks Market Edge Highlights: UnitedHealth, Centene, MasTec, Bank of America and Bristol-Myers Squibb
by Zacks Equity Research
Zacks Market Edge Highlights: UnitedHealth, Centene, MasTec, Bank of America and Bristol-Myers Squibb
Could the Trade War be Bullish for Stocks?
by Tracey Ryniec
Tariffs, tweets, negotiations, the Fed cutting rates, full employment, a manufacturing slowdown: how investors can cut through the noise.
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $232.46, marking a +0.77% move from the previous day.
Centene's Unit, Canopy Health Extend Ties to Improve Care
by Zacks Equity Research
Centene's (CNC) subsidiary Health Net extends collaboration with Canopy Health to cater wider reach to its CaIPERS members.
Ensign Group Acquires Nursing Facility to Expand in Idaho
by Zacks Equity Research
Ensign Group (ENSG) purchases the real estate and the operations of Temple View Transitional Care Center in Idaho to boost its presence in the state.